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ABSTRACT
A long-standing question in biology is whether multipotent somatic stem and progenitor cells
(SSPCs) feature molecular properties that could guide their system-independent identification.
Population-based transcriptomic studies have so far not been able to provide a definite answer,
given the rarity and heterogeneous nature of these cells. Here, we exploited the resolving
power of single-cell RNA-sequencing to develop a computational model that is able to accu-
rately distinguish SSPCs from differentiated cells across tissues. The resulting classifier is based
on the combined expression of 23 genes including known players in multipotency, proliferation,
and tumorigenesis, as well as novel ones, such as Lcp1 and Vgll4 that we functionally validate
in intestinal organoids. We show how this approach enables the identification of stem-like cells
in still ambiguous systems such as the pancreas and the epidermis as well as the exploration
of lineage commitment hierarchies, thus facilitating the study of biological processes such as
cellular differentiation, tissue regeneration, and cancer. STEM CELLS 2017; 00:000–000
SIGNIFICANCE STATEMENT
This novel transcriptomics-based approach exploits the increased molecular resolution provided
by single-cell RNA-sequencing to accurately identify somatic stem and progenitor cells (SSPCs)
across a wide range of tissues. The developed classifier uniquely combines expression informa-
tion of only few genes, suggesting that SSPCs share specific molecular properties across tissues.
The method provides a valuable resource to identify SSPCs and order them across differentia-
tion stages in yet poorly characterized systems. Among its downstream applications we envi-
sion, besides the detection of novel stem-like cells, the estimation of the fraction of SSPCs in a
heterogeneous sample or, in an expanded version, the detection of highly malignant cells in
tumors.
INTRODUCTION
The identiﬁcation and molecular characterization
of multipotent somatic stem and progenitor cells
(SSPCs) is of fundamental interest for understand-
ing development, homeostasis, and regeneration
of complex multicellular organs. In addition, the
study of cells with multipotent capacity provides
novel regenerative therapy opportunities [1] as
well as new insights into disease mechanisms or
treatments [2]. While hematopoietic, neural, epi-
dermal, and gastrointestinal stem cells have
already been phenotypically well-characterized, it
has proven very challenging to identify SSPCs and
establish their hierarchy in a broad range of other
systems, including the lung, kidney, mesenchyme,
heart, liver, and pancreas [3–5]. This is largely
because such SSPCs tend to constitute small and
heterogeneous populations that reside in tissues
of complex composition and lack universal
markers, which leads to technological or experi-
mental limitations such as population-level molec-
ular measurements and tedious in vivo functional
assays [6].
Recent advances in single-cell genomics have
revolutionized our ability to reveal the composi-
tion of individual tissues or speciﬁc developmen-
tal patterns [7–10]. To determine which single-
cell RNA-sequencing (scRNA-seq)-assessed cells
are stem-like, studies tend to cluster or arrange
them along a differentiation time-line (termed
“pseudo-time”) and attribute labels to groups
based on marker gene expression [8–11]. This is
an iterative and highly variable process, as it is
sensitive to particular algorithmic (clustering,
graph walking etc.) as well as biological (markers,
cell stages) choices. The recently developed
StemID alleviates these issues by streamlining
the procedure, but it is only applicable to cells
aLaboratory of Systems
Biology and Genetics,
Institute of Bioengineering
and Swiss Institute of
Bioinformatics, CH-1015
Lausanne, Switzerland; bISREC
(Swiss Institute for
Experimental Cancer
Research), School of Life
Sciences, Ecole Polytechnique
Federale de Lausanne (EPFL)
Correspondence: Bart
Deplancke, Ph.D., Laboratory of
Systems Biology and Genetics,
Institute of Bioengineering,
School of Life Sciences, Ecole
Polytechnique Federale de
Lausanne (EPFL) and Swiss
Institute of Bioinformatics,
Station 19, CH-1015 Lausanne,
Switzerland. Telephone:
141216931821; e-mail: bart.
deplancke@epfl.ch
Received April 5, 2017;
accepted for publication
October 2, 2017; ﬁrst published
online in STEM CELLS EXPRESS
October 16, 2017.
http://dx.doi.org/
10.1002/stem.2719
This is an open access article
under the terms of the Creative
Commons Attribution NonCom-
mercial License, which permits
use, distribution and reproduc-
tion in any medium, provided
the original work is properly
cited and is not used for com-
mercial purposes.
STEM CELLS 2017;00:00–00 www.StemCells.com VC 2017 The Authors STEMCELLS published by Wiley Periodicals, Inc.
on behalf of AlphaMed Press
STEM CELL TECHNOLOGY: EPIGENETICS,
GENOMICS, PROTEOMICS, AND
METABONOMICS
across multiple differentiation stages and not to homogeneous
single-cell populations [12]. For such cases, one is obliged to
leverage on the knowledge accumulated in other systems to
assign functionality. To formalize such an approach, we developed
a cross-tissue SSPC identiﬁcation method.
A wide range of efforts have already been directed toward
delineating a stem cell (SC) molecular signature (referred to
as “stemness” signature) [13–19]. For example, over 100
stemness-related resources, including curated gene sets, com-
putationally derived signatures, and transcription factor (TF)
targets have been collected and made centrally available
through the online platform StemChecker [20]. Importantly,
while there is substantial overlap between the individual
resources, there is by no means a consensus on the molecular
program that underlies the core properties of SSPCs [20] or a
universally accepted marker gene set that facilitates their
identiﬁcation [6]. This may be because SSPCs may only be
captured through a combination of system-speciﬁc features
rather than single marker genes [4, 16, 21]. At the same time,
while scRNA-seq studies revealed cell hierarchies and novel
cell types within systems of interest [7–10, 22–24], cross-
study analyses have so far only focused on cell cycle stage
identiﬁcation [25]. In this study, we aimed to bridge this gap
by exploring how well multipotent SSPCs could be identiﬁed
and distinguished from differentiated cells based on scRNA-seq
data. We demonstrate here that a lasso logistic regression-
based model is able to accurately identify various SSPCs by
using a unique combination of genes that together reach good
cross-system performance.
MATERIALS AND METHODS
In our approach, we carefully considered (a) the quality/
diversity of the training data, (b) the genes included as
features in the training, (c) the algorithm used, and (d) the
normalization applied prior to training, exploring several
options in order to obtain a robust model.
Datasets
We used the following data, also listed in Supporting Informa-
tion Table S1: (1) as positive SSPCs, (a) as train and test data,
we included quiescent and activated neural stem cells
assessed after injury (qNSCs and aNSCs, d1) [10], macrophage
dendritic cell progenitors (MDPs, d2) [22], hematopoietic stem
cells (HSCs, d3, and d4) [26, 27] and (b) as independent test
data quiescent and activated NSCs (qNSCs and aNSCs, d9)
[28], mesenchymal stem cells (MSCs, d10) [29], short- and
long-term HSCs (stHSCs and ltHSCs, d11–12) [30], intestinal
stem cells (ISCs, d13) [9]; (2) as negative data (non-SSPCs), (a)
as train and test data, we included astrocytes (STR and CTX,
d5) [10], T cells (d6) [31], AT2 lung epithelial cells (AT2 cells,
d7) [8], and adult non-stem neuronal cells (neuro, d8) [23]
and (b) as independent test data non-stem intestinal cells
(REG41 and LGR5-, d14–15) [9], lymphoblastoid cell lines
(LCLs, d16) [32], adult non-stem neuronal cells (neuro, d17)
[33] as well as adult hepatocytes and endothelial cells isolated
from human liver (d33) [34]. To test predictions on cells
with a gradually decreasing level of stemness, we used: (a)
oligodendrocytes (Oligo, d18), neuroblasts (NB, d19), neural
transit amplifying cells (TAPs, d20), activated and quiescent
NSCs (aNSCs and qNSCs, d21–22); (b) megakaryocyte progeni-
tor cells (CD150- MkPCs, d23); (c) dendritic cell precursors
(PreDCs, d24) and common dendritic cell progenitors (CDPs,
d25) [22]; (d) an unsorted mixture of cells progressively
loosing progenitor status from embryonic day 14 over 16 to
18 (E14, E16, and E18, d26–27) [8]. To keep the fraction of
positive and negative cells balanced, we selected only a
(random) subset of cells among those that were part of large
datasets: d7, d8, and d11–12 [23, 30, 31]. Finally, we used
dissociated mouse epidermis cells [35] as well as human
pancreas cells [12, 36, 37] for generating novel predictions.
Data Normalization
We used the expression estimates provided by the individual
studies, which were publicly available through Gene Expression
Omnibus [38], irrespective of the underlying experimental and
computational methods that they were based on (Supporting
Information Table S1). For developing the stem and progenitor
cell identiﬁcation model, due to the highly heterogeneous
nature of scRNA-seq, exacerbated by both experimental and
data processing methodological differences among the studies
as well as variability across distinct biological sources, we did
not use these raw expression estimates. Rather, we applied
rank-based normalization and reduced the dynamic range of the
data by using quantiles instead of ranks or expression estimates.
We ran the lasso logistic regression model described below on a
range of ranked data (for non-zero data points: 10, 20, 30, 50,
100, 500, 1,000, and 1,500 quantiles, with zero as an additional
lowest rank in each set; plus the full ranked matrix, Supporting
Information Fig. S2A), ﬁnding that differences in the binomial
deviances were minimal. We further used ventiles (20-
quantiles), which showed minimal average values, for all
reported results.
To generate the t-SNE maps [39] with the R library Rtsne, we
used log-normalized expression estimates of all genes having
maximal log expression across all cells in the datasets c,
where c was calculated for each dataset to equal the third quar-
tile of log expression estimates of a reference gene set (house-
keeping genes and ERCC spike-ins when available) expressed
in 50% of all cells. Cells in which a high fraction ( third
quartile1 2*standard deviation across all cells) of reference
genes were not measured (50) were removed from the analysis
in a ﬁrst step.
Model Training and Testing
We trained lasso logistic regression (cv.glmnet  nfolds5 10
type.measure5“deviance” lower.limit5 0 family5“binomial”
alpha5 1), elastic-net logistic regression (cv.glmnet 
nfolds5 10 type.measure5“deviance” lower.limit5 0 family-
“binomial” alpha5 0.5), and random forest (randomForest
importance5 T proximity5 T ntree5 1000) models on
two thirds of d1–8 and tested them on the remaining one
third as well as on the full d10–28 (Supporting Information
Fig. S2B, S2C; Table S1) datasets, using the R libraries glmnet
[40] and randomForest [41]. We used a set of 4,528 genes
commonly annotated (but not necessarily expressed) in all
train and test data (d1-d28) (All.g; Supporting Information
Table S3) as starting features. We deﬁne commonly annotated
genes as human-mouse orthologous genes with shared gene
symbol across species and for which expression information
(even if equal to 0) is present across all used datasets. For
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comparison, we also trained: (a) lasso logistic regression models
(cv.glmnet  nfolds5 10 type.measure5“deviance” low-
er.limit5 0 familiy5“binomial” alpha5 1) using as features
only genes part of previous population-derived stemness signa-
tures—PluriNet [42] and Wong et al. [43] (Lasso.LogReg, l1.Pluri-
Net.g, and l1.Wong.g); (b) logistic regression models (glm
family5“binomial”) using as features only genes part of previ-
ous population-derived stemness signatures—PluriNet [42] and
Wong et al. [43] or retained from the full set of 4,528 genes after
l1 (lasso) regularization (LogReg, PluriNet.g, Wong.g, and SSPCI.g);
(3) a logistic regression model (glm family5“binomial”)
using as features the predicted probabilities for a cell to be in
G1 or G2/M phase of the cell cycle [25] (Fig. 2A, 2C, Supporting
Information Fig. S2B, S2C and Table S3). We also calculated the
average correlation between a cell’s gene expression and the
average expression of known positive SSPCs (using log-
normalized expression estimates of the 4,528 shared genes and
Spearman’s rank correlation coefﬁcient), exploring how well
this measure can be used to classify cells (Fig. 2A, 2C). ROCR
curves were generated to visualize the performance of all dis-
tinct trained models on both the test and the independent test
datasets using the ROCR R package (performance
”tpr”,”fpr”) [44].
The ﬁnal reported model (referred to as SSPCI), was trained
using lasso logistic regression and cross-validation, as imple-
mented in the R library glmnet [40] (cv.glmnet  nfolds5 10
type.measure5“deviance” lower.limit5 0 familiy5“binomial”
alpha5 1 ). We generated predictions on new data using the
function predict with the parameters pred.type5 response
for obtaining ﬁtted probabilities of class 1, referred to as
“stemness probabilities.” We used pred.type5“class”
s5 lambda.1se  for binary predictions (15 SSPC, 05 non-
SSPC), corresponding to the largest value of lambda for which the
error is within one standard error of the minimum. Stemness
probabilities were displayed using the function beanplot [45] (
what5 c(1,1,1,0) overallline5 “median” log5““bw5“nrd0” ).
The model was trained on two thirds of the data by 10-fold-cross-
validation and then tested on the remaining one third of the data
(not used for parameterization) as well as the completely inde-
pendent test data. Feature selection was automatically per-
formed by the lasso regularization, which sets the coefﬁcients of
a large number of genes to zero. The intersection of features
retained >10% of the time (>10 across 100 repetitions) was fur-
ther used as ﬁnal feature set, corresponding to 23 genes in the
ﬁnal model. By constraining the model withlower.limit5 0,
we only obtained positive coefﬁcients, more easily biologically
interpretable as genes associated with SSPCs. We refer to the
probability of being classiﬁed as positive as the “probability (p) of
stemness” and to the cells predicted as positives (i.e., p .5) as
“somatic stem and progenitor cells” or “SSPCs” throughout the
manuscript.
Gene Sets
One constraint of the initial training gene set is that it should
ideally contain universally expressed orthologous genes across
mouse and human, which are likely to be present in a new pre-
diction dataset. The intersection of all our train and test data
(d1-d28, irrespective of their expression level) resulted in 4,528
genes (All.g; Supporting Information Table S3), the majority of
which we assume is likely to be universally measurable and thus
present in future datasets. We assessed the robustness of the
obtained gene signature to variations in the initial starting gene
set by altering the test data (removing one or two datasets, and
thus starting with 4.841, 6.803, and 7.317 genes, respectively),
or by subsampling (10 repetitions) from the largest (7.317
genes) initial gene set. The vast majority (19 of 23) of signature
genes were also retained in 80% of these alternative starting
sets (Supporting Information Fig. S5C, Table S4). Moreover,
among the top 10 signature genes ordered by logistic regression
coefﬁcient (and thus relative importance), 9 were retained in
>80% of all tested models. Together, these results strongly sug-
gest that the gene signature used by the classiﬁer is robust.
Furthermore, we used genes part of previous population-
derived stemness signatures—PluriNet [42] and Wong et al. [43]
(PluriNet.g and Wong.g) to test how informative they are in sepa-
rating scRNA-seq assessed SSPCs from non-SSPCs, as well as gene
sets previously speciﬁcally associated with ISC function (1: previ-
ously used ISC marker genes, as listed on Wikipedia on 03.12.2015,
ISC.g1 and 2: Munoz et al. ISC signature genes, ISC.g2 [46]), genes
annotated with the “cell cycle” GO Term (GO:0007049) (Cyc.g),
genes annotated with various differentiation and stemness-related
terms, including “differentiation,” development,” “stem cell main-
tenance,” “stem cell development,” stem cell division,” “stem cell
commitment” (“GO:0030154,” “GO:0048468,” “GO:0019827,”
“GO:0048864,” “GO:0017145,” “GO:0072089,” “GO:0048865,”
“GO:0048863”) (Diff.g), and genes annotated with the
“Metabolism” GO Term (GO:0008152) (Metab.g) to validate
the biological relevance of the reported stemness probability
(Supporting Information Table S3). We calculated the Spearman’s
rank correlation coefﬁcient (rho) of the stemness probability with
the expression level of genes in these sets. We found that the
correlations obtained for the two ISC-speciﬁc gene sets were signif-
icantly higher than those obtained for the background or for all
other gene sets (p .005 for any of the comparisons, Wilcoxon
rank sum test), suggesting that our approach indeed uncovered
genes that are functionally relevant for stemness.
To identify stemness-speciﬁc genes in the intestinal orga-
noids [9] (Supporting Information Table S3, ISC.g3), in the
human pancreas [12, 36] (Supporting Information Table S2),
and in the mouse epidermis [35] (Supporting Information
Table S2) based on stemness probability, we took a two-step
approach: (a) we only included genes expressed (>0 read
counts) in 60% of the predicted positives and 20% of the
predicted negatives and (b) we only included genes with a log
expression estimate highly correlating (Pearson’s r, FDR 0.05)
with the stemness p. Finally, we analyzed the properties of
genes retained by SSPCI (SSPCI.g) using StemChecker as well
as gene ontology (Supporting Information Table S4).
We also used a list of “housekeeping” genes, expected to
be universally expressed at similar levels across diverse
scRNA-seq data based on their presence (>50% of cells) and
high (FDR 0.05) Gaussian rank correlation with ERCC spike-ins
in 2 datasets (Supporting Information Table S3).
Other Methods
Comparisons of stemness probabilities and expression values
were performed using one-sided Wilcoxon rank sum tests and
the signiﬁcance of overlaps was assessed using one-sided Fisher’s
exact tests. The gene ontology enrichment was performed using
the topGO library, theelimCount method and a p value cut-
off of .001. Overlaps with population-derived signature gene sets
were assessed using the webserver StemChecker [20]. Cell cycle
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stages were predicted using Cyclone with default parameters and
based on known markers [25]. All analyses were performed using
R version 3.1.1 and Bioconductor version 3.0.
For the intestinal organoid analyses, statistical computa-
tions were performed using GraphPad Prism6. Experimental
data are presented as mean6 standard deviation. Statistical
signiﬁcance was assessed by two-tailed unpaired Student’s t
test; the data were considered not signiﬁcant (ns) for p> .05.
Mouse Model
Animal experiments were performed in accordance with pro-
tocols approved by the “Service de la Consommation et des
Affaires Veterinaires” of Canton Vaud, Switzerland. APCmin
mice were described previously [47]. This strain was back-
crossed onto C57BL/6 for at least 10 generations.
Isolation of Intestinal Tissue and Organoid Culture
Organoid cultures were established from total intestinal crypt
preparations of APCmin mice as described previously [48].
Freshly isolated small intestines were incised along their
length and villi were removed by scraping. Then, the adeno-
mas were isolated and after several washes, the tissue was
incubated in PBS/EDTA (Sigma-Aldrich, St. Louis, MO, US)
(2 mM), pH8 for 5 minutes at 48C. Gentle shaking removed
remaining villi, and intestinal tissue was subsequently incu-
bated in phosphate-buffered saline (PBS)/EDTA (2 mM), pH8
for 30 minutes at 48C. Upon dissociation, samples were
passed through a 70 lm ﬁlter and washed four times in cold
Advanced Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)/F12,
(Gibco, NY, US) media. Afterward crypt cells were embedded
in Matrigel (BD Biosciences, San Jose, CA, US) and plated in
400 ll of organoid media (Advanced DMEM/F12 with B27,
N2, and N-acetylcysteine; containing growth factors EGF 50
ng/ml (Invitrogen, NY), R-Spondin 1 mg/ml, Noggin 100 mg/ml)
into 24-well plates at a concentration of 500 crypts per well.
Growth factors were added every other day and the entire
medium was changed every 4 days. Secondary organoid cul-
ture was achieved by removing the organoids from Matrigel
followed by mechanical dissociation with a glass pipette, gen-
tle centrifugation (800 rpm), and then transferred to fresh
Matrigel. Serial passaging (passage 1, passage 3, and passage
4) of shRNA-expressing organoids was compared to control
organoids.
Plasmids, shRNAs, and Protein Production
Lcp1 (50 TTGAAGAGATCGTCGGTGTTGG 30) and Vgll4 (50
TCACTGCTGTTCTTAGTCAGGG 30) were suppressed by shRNAs
with the indicated antisense oligos in a MIR30 backbone
expressed from a lentiviral vector (pSM2, Openbiosystems).
The expression plasmid for R-spondin1 was a kind gift from
Calvin Kuo (Standford University, U.S.) and this and Noggin
proteins were produced as published [49] using proteinG or
Ni-NTA puriﬁcation, respectively.
Cell Culture and Selection of shRNA-TurboRFP Gene
Suppression Cells by Flow Cytometry
The mouse colon carcinoma-derived cells CT26 were cultured
in DMEM 10% fetal bovine serum (FBS, Invitrogen, NY, US).
The shLcp1-TurboRFP, shVgll4-TurboRFP, and their respective
controls were generated by lentiviral transduction. To this
end, we generated a lentiviral vector driving TurboRFP
expression that enables identiﬁcation of positive cells by ﬂuo-
rescence-activated cell sorting (FACS). TurboRFP1 cells were
sorted from a population of transduced cells by ﬂow cytome-
try (FACSAria II; Beckton Dickinson (BD) Biosciences, Franklin
Lakes, NJ, USA, or MoFlo; Dako, Hamburg, Germany).
Lentiviral Production and Transduction
Lentiviruses were generated in 293T cells using third genera-
tion lentivirus packaging vectors, and virus particles were con-
centrated by ultracentrifugation for 2 hours at 22,000 rpm.
Lentiviral titration was performed in 293T cells. Cell lines were
infected with lentiviruses overnight at 378C. Colon carcinoma
cell lines (CT26) and murine intestinal organoids were infected
by lentiviral transduction as published [50]. Lentiviral infection
was performed after 5 minutes Trypsin-EDTA (378C) organoid
dissociation. After several washes with 5%FBS-PBS, the cells
were spun with the lentiviral particles at 1,300 rpm for 20
minutes and incubated with organoid media for 2 hours at
378C. The pellet of single cells was then embedded in Matri-
gel and fresh organoid medium was added. Single cells gave
rise to organoids after 10 days of culture. Images and qRT-
PCR analyses were performed between day 13 and 17. Serial
passaging was then performed at the following time points:
P1 day 18, P2 day 28, P3 day 35, and P4 day 40.
Real-Time-qPCR
RNA was prepared using the mini or micro RNA kit (Qiagen,
Germany) from organoids. cDNAs was synthesized using
Superscript-II reverse transcriptase (Invitrogen, NY, US) and
oligodT priming. qPCR was performed in a StepOnePlus ther-
mocycler (Applied Biosystems Thermo Fisher, NY, US) using
the Power SYBR green PCR Master Mix (Applied Biosystems,
Thermo Fisher, NY, US) and the speciﬁc primers are listed
below. Relative gene expression was determined by the com-
parative CT method.
Murine
gene Forward primer Reverse primer
Anpep CCTGTAGCAAAGATGTGTGGATT GGATGAGATTGGCAAAGGAGAAA
Lgr5 CTCCACACTTCGGACTCAACAG AACCAAGCTAAATGCACCGAAT
MKi67 GATGGAAGCATTGTGAGAACCA CCTGCTCTTCCACAGATTCAAG
Tff3 CTTTGACTCCAGTATCCCAAATG TGGCTGTGAGGTCTTTATTCTTC
Vdr AGGGACGTATCTTCAAACTCCA AACGCATGATCAGCAAGAAGTA
Wwp1 ATGATGGCCAGTCTTCAAAAGT GACATCCTACCTGAAAGCAACC
shLcp1 AACAAAGCCCTGGAGAATGAC TGTTGATCGTTCTCTCGTCAA
shVgll4 CCACCTGTACGCATCTCTCC GCCTGTGTCACTGCTGTTCTTA
RESULTS
Accurate Identification of SSPCs Across Biological
Systems
We collected diverse publicly available scRNA-seq data across
biological systems and germ layers (Fig. 1, Supporting Infor-
mation Fig. S1; Table S1, and Methods), using only two-thirds
of the cells from each dataset (138 positives consisting of
mostly stem cells but also early progenitors, including neural
and hematopoietic stem cells as well as MDPs, and 170 nega-
tives consisting of differentiated cells such as neuronal cells, T
cells, and lung epithelial cells) for 10-fold-cross validation-
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based feature (gene) selection and parameterization. We sep-
arately retained a test set (one-third, 69 positives and 85 neg-
atives) completely untouched during training and also used
completely independent (467 positives and 554 negatives,
including distinct studies and germ layers) test data (Fig. 1,
Supporting Information Table S1 and Methods). We note that
for simplicity, we refer to the probability of being classiﬁed as
positive as the “probability (p) of stemness” and to the cells
predicted as positives (i.e., p .5) as “somatic stem and pro-
genitor cells” or “SSPCs” throughout the article.
We evaluated a broad range of models on both test and
independent test data and found that de novo lasso logistic
regression (referred to as somatic stem and progenitor cell
identiﬁer, SSPCI, hereafter) showed best overall performance,
followed by de novo elastic-net logistic regression and de
novo randomForest (Fig. 2A–2D, Supporting Information Fig.
S2B, S2C and Methods). While average correlation-based and
logistic-regression models trained on population-derived stem-
ness gene sets (both with or without regularization) per-
formed only marginally inferior to SSPCI on the test samples
(Fig. 2A), they showed worse performance on the indepen-
dent test samples (Fig. 2C). Remarkably, SSPCI identiﬁed 89%
of all SSPCs and 97% of all non-SSPCs as such (Fig. 2B, 2D,
Supporting Information Table S1).
Importantly, SSPCI was also able to identify SSPCs in
completely independent biological systems such as the mouse
intestine [9], corresponding to a germ layer not originally cov-
ered in the training data (Fig. 2D, 2E, Supporting Information
Fig. S2D). In particular, LGR51 ISCs were attributed signiﬁ-
cantly higher stemness probabilities than the LGR5- cells (Fig.
2E, p5 10232, Wilcoxon rank sum test) and only 17 (of a total
of 229) LGR5-cells were classiﬁed as positives. All of the latter
were transcriptionally similar to the LGR51 population, as
visualized in a 2D t-SNE projection [39] (Fig. 2E, Supporting
Information Fig. S2D). These cells likely represent highly prolif-
erative and multipotent transit amplifying cells and are also
partially characterized by high expression of Hopx and Gnl3,
other commonly used stem cell markers (Fig. 2E, Supporting
Information Fig. S2D) [46, 51, 52]. It is thus possible that
some of these misclassiﬁcation events do not represent false
positive predictions, as these multipotent cells may genuinely
be very close to ISCs and may thus also be categorized as
SSPCs [5]. As an additional control, we tested the classiﬁer on
human liver data and conﬁrmed that neither adult hepato-
cytes nor endothelial cells were classiﬁed as positives (Sup-
porting Information Fig. S2E, S2F).
We next asked whether the cell cycle stage of the cells
inﬂuences the performance of the classiﬁer, given that prolif-
eration and the ability to self-renew by cell division are intrin-
sically linked to stemness. To do so, we used a recently
developed scRNA-seq-based method to attribute each cell to
one speciﬁc cell cycle stage (G1, G2/M, S or if the assignment
is ambiguous, na) [25]. This analysis revealed that across all
our datasets, SSPCs did not show an association with a spe-
ciﬁc cell cycle stage (Fig. 2E, Supporting Information Fig. S2G,
S2H). Furthermore, we found that a linear regression model
trained using only the probabilities of cells being in one of
the three cell cycle stages as features performs very poorly in
identifying SSPCs (Supporting Information Fig. S2B, S2C). Thus,
we conclude that SSPCs cannot be identiﬁed solely based on
their cell cycle stage.
De Novo Identification of SSPCs in scRNA-Seq
Dissected Tissues
We subsequently tested the power of our approach to resolve
still ambiguous systems that were recently dissected by
scRNA-seq: the human pancreas [12, 36, 37] and the mouse
epidermis [35]. In the pancreas, we found that virtually all
Figure 1. Classiﬁcation strategy. Datasets used for training and testing of the models, see Supporting Information Table S1 for full
description. Abbreviations: SSPCs, somatic stem and progenitor cells; SCs, stem cells; LCLs, lymphoblastoid cell lines.
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tested endocrine cells (alpha, beta, gamma, and delta) had
very low stemness probabilities and were classiﬁed as nega-
tives (Fig. 3A–3E). This result is in line with the notion that
proliferation of differentiated cells is the main mechanism
active in the islets [53, 54]. In contrast to endocrine cells, a
substantial (10%–60%) percentage of ductal, acinar, and most
notably stellate cells showed high stemness probabilities and
were predicted positive (Fig. 3A–3E). Importantly, these
results were highly consistent across three independent stud-
ies (Fig. 3A–3E) [12, 36, 37], and individuals [36] (Supporting
Information Fig. S3A, S3B), demonstrating the robustness of
our approach to laboratory-induced variability. Our ﬁndings
are compatible with the increased clonogenic capacity and
phenotypic plasticity of these three cell types compared to
endocrine cells [55]. They also support the notion that stellate
cells are major contributors to pancreatic maintenance and
repair [56, 57], as our prediction suggests that the stellate cell
fraction contains most SSPCs in this system. Interestingly,
both disease (type I and II diabetes, respectively), and age
seems to alter the SSPC proportion in the pancreas, with a
higher fraction of stem-like cells in affected adults as well as
healthy children compared to healthy adults (Fig. 3E). This is
consistent with the observation of increased de-differentiation
of alpha and beta cells in diabetes patients compared to adult
controls [37].
A second system that we examined is the mouse epider-
mis. Using scRNA-seq of thousands of epidermal cells, our
predictor revealed almost twice as many SSPCs among basal
cells compared to all other cells (Fig. 3F, left), and interest-
ingly, no difference in the fraction of predicted SSPCs
between basal cells expressing at least one of the epidermal
stem cell markers Cd34, Lgr5, Lgr6, Gli1, Lrig1, Krt14, and
those not expressing any (Fig. 3F, right). Surprisingly, when
examining which subclass of basal cells is predicted to contain
most SSPCs, we found that it is the interfollicular epidermis
(IFE), with 7%–13% of stem-like IFE basal cells compared to
only 4% of bulge cells (Fig. 3G). We thus focused on the IFE
area and examined where high scoring cells are positioned on
the previously estimated differentiation trajectory [35]. We
found that these cells are indeed largely located at the root
of the trajectory (Fig. 3H). Consistently, our predicted
stemness probability was signiﬁcantly negatively correlated to
previously estimated differentiation pseudotime values (Spear-
man’s rho520.417, p< 1025). In sum, our analysis supports
the notion that there is no speciﬁc subcluster of SSPCs in the
epidermis [58], as this system appears characterized by
Figure 2. Accurate classiﬁcation of somatic stem and progenitor cells. Receiver operating characteristic (true positive rate vs. false posi-
tive rate across all cutoffs) plots for distinct classiﬁers as assessed on all test (A) and independent test (distinct experiments or studies,
(C) data, including SSPCI, the best performing model (de novo lasso-logistic-regression, blue, continuous line), models trained on
population-derived stemness gene sets (yellow, Wong et al. [43] and green, PluriNetwork [42]) as well as the correlation with gene
expression-based classiﬁcation (black) (Methods). (A, C) The fraction of cells predicted positive (blue) and negative (gray) for each of the
test (B) and independent test (D) datasets by SSPCI. The total number of cells as well as those used for testing only (in brackets) per
each dataset is indicated. Supporting Information Table S1 contains information on the full dataset, including acronym legends. (E) t-SNE
maps of intestinal epithelial ex vivo and organoid-derived LGR51 (classically considered SCs, red) and LGR5- (assumed to be non-SCs,
gray) cells [9]. Predicted stemness probabilities (gradient gray-orange-blue), binary classiﬁcation outcome (blue: SSPC, gray: non-SSPC) by
SSPCI, as well as predicted cell cycle stage [25] (light green: G1, light brown: S, dark brown: G2/M, gray: not assigned-na) are indicated
for all cells. Abbreviations: ltHSCs, long-term hematopoietic stem cells; MDPs, macrophage dendritic cell progenitors; NSCs, neural stem
cells; (n)SSPC, (negative) somatic stem and progenitor cell; stHSCs, short-term hematopoietic stem cells; MSCs, mesenchymal stem cells;
ISCs, intestinal stem cells.
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interspersed, preponderantly basal cells with stem-like expres-
sion patterns. We found that many of the latter cells are
located in the IFE and the upper hair follicle region, as also
suggested recently [35].
Finally, for all predicted SSPCs in both systems, we
highlighted their associated genes (Supporting Information
Table S2; Fig. S3C, S3D), which can guide follow-up experi-
ments aimed at their isolation and characterization or validate
previously reported associations. For example, it has been
recently suggested that the TF STMN1 may act as a marker
for progenitor-like acinar cells [59]. Our data supports this
association given that its expression is highly correlated with
acinar SSPCs in both pancreas datasets (Supporting Informa-
tion Table S2; Fig. S3E, S3F).
Toward a Quantitative Measure of Multipotency
Prediction results on the intestinal, pancreas, and epidermal
data suggested that intermediate stemness probabilities may
reveal cells in transition stages between multipotent SSPCs
and fully differentiated cells (Fig. 2E, 3A–3E, Supporting Infor-
mation Fig. S2D). To test the capacity of our classier to distin-
guish among stem-like and differentiated cells, we analyzed
Figure 3. Predicted stem-like cells in human pancreas and mouse epidermis. (A, C, E): The probability of a positive prediction, referred
to as “stemness” probability, for endocrine (alpha, beta, gamma, and delta) and exocrine (acinar, ductal, activated/quiescent stellate)
cells using three distinct datasets (A: Baron et al. 2016 [36], C: Gruen et al. 2016 [12], and E: Wang et al. 2016 [37]). (B, D): The fraction
of cells that were predicted positive (blue) and negative (gray) for each of the cell types in A, C. (F): The fraction of epidermal cells pre-
dicted positive among the categories: nonbasal, basal, basal with expression of at least one epidermal stem cell marker (1 SC marker),
or basal with no expression of any epidermal stem cell markers (no SC marker). (G): The fraction of epidermal basal cells predicted posi-
tive among seven distinct previously determined clusters [35]. The anatomical location of cells in each cluster is indicated (IFE–inter-fol-
licular epidermis, uHF–upper hair follicle). (H): t-SNE maps of cells in the IFE, corresponding to a temporal progression from most
undifferentiated (basal, green), to terminally differentiated (term. diff., in red) cells [35]. Predicted stemness probabilities (gradient gray
to blue) and binary classiﬁcation outcome (blue: SSPC, gray: non-SSPC) are depicted for all cells. Abbreviations: (n)SSPC, (negative)
somatic stem and progenitor cell; SC, stem cell
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four distinct systems featuring cells with increasing level of
commitment: (a) lung development [8], (b) dendritic cell
development [22], (c) megakaryocyte differentiation [26] and
neurogenesis [10] (Fig. 4A, Supporting Information Table S1).
In all of these datasets, we observed a progressive decrease
in stemness probabilities across time/differentiation (Fig. 4A,
Supporting Information Fig. S4A; Table S1). For instance, while
the vast majority of multipotent MDPs and CDPs were pre-
dicted as positives, the stemness probabilities assigned to
CDPs were signiﬁcantly lower (p5 1029, Wilcoxon rank sum
test) and further, the majority (68%) of dendritic cell precur-
sors (PreDCs) were identiﬁed as negatives (Fig. 4B, Supporting
Information Fig. S4A). These results suggest that the stemness
probability provided by our classiﬁer can be used as a
quantitative indicator of a cell’s progression along a speciﬁc
differentiation path, independently of the cell’s particular cell
cycle stage at the time of measurement (Supporting Information
Fig. S4B, S4C).
Having established that our derived stemness probability is a
robust indicator of a cell’s differentiation status, we next asked
whether it could be used to functionally associate genes with
stemness. The large number of stem and non-stem cells present
in the intestinal organoid data [9] enabled us to explore this ques-
tion in detail. Among genes that showed signiﬁcant expression
correlation with stemness probability and that were largely con-
ﬁned to cells predicted as positives (Methods), we identiﬁed the
bona ﬁde stemness marker LGR5 as well as other surface-
associated stem cell markers such as GNL3 and CD44 (Fig. 5A). A
broad range of TFs were also among these genes as well as sev-
eral metabolic factors such as PHGDH, which is part of the known
intestinal SC (ISC) signature [46] (Fig. 5A). In total, we found 98
genes that were ISC-associated (ISC.g3, Supporting Information
Table S3), representing known (26% overlapped with an ISC stem-
ness signature) and putatively novel players in ISC function. Gene
set enrichment analysis also revealed terms previously associated
with stem cell function, including retinoic acid signaling, DNA
replication, cell cycle, and proliferation (Supporting Information
Fig. S5A).
Signature Genes Are Required for a Stem-Like
Phenotype
Given the robust performance of our classiﬁer across biological
systems, we reasoned that some of the genes that were
retained in our model (Methods and Supporting Information
Table S4) are likely to be more generally required for SSPC func-
tion. Using the resource collection “StemChecker” [20], we thus
asked which of these 23 genes (Fig. 5B) had previously been
implicated in stem cell biology. We found that 70% of them
Figure 4. The predicted stemness probability decreases as cells become increasingly differentiated. (A): The probability of a positive
prediction, referred to as “stemness” probability, for four groups of cells showing various degrees of lineage commitment and differenti-
ation. E14, MDP, 1501, and NSC (a–activated and q–quiescent) represent the least and E18, PreDCs, 150- and Oligo the most commit-
ted/differentiated cell type for each group. Supporting Information Table S1 contains information on the full dataset, including acronym
legends. (B): t-SNE map of the complete dendritic cell differentiation dataset [22], including MDP (black), CDP (green), and preDC (light
brown). Predicted stemness probabilities (gradient gray to blue) and binary classiﬁcation outcome (blue: SSPC, gray: non-SSPC) are
depicted for all cells. Abbreviations: MDP, macrophage dendritic cell progenitor; CDP, common dendritic cell progenitor; PreDC, dendritic
cell precursor; NSC, neural stem cell; TAP transit amplifying cell; NB neuroblast; Oligo, oligodendrocyte; (n)SSPC, (negative) somatic stem
and progenitor cell.
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were part of at least one population-derived stemness gene set,
most often characteristic of neural, hematopoietic, or intestinal
SCs (Bonferroni adjusted p .03) (Fig. 5B, 5C, Supporting Infor-
mation Table S4). Thus, while the majority of our classiﬁer genes
are individually part of population-derived stemness gene sets,
they have not been previously used collectively to discriminate
SSPCs from differentiated cells.
Interestingly, 12 out of the 23 classiﬁer genes showed sig-
niﬁcantly higher expression in ISCs versus all other cells (Sup-
porting Information Fig. S5B; Table S4). This is despite the fact
that no ISCs, or any other endodermal SSPCs, have been used
for training the model. Among genes with higher expression
in ISCs were those that have already been implicated in ISC
biology such as Myc and Ccnd2 [60, 61] (Fig. 5D, Supporting
Information Fig. S5B). Others have only been partially linked
to cell differentiation, and have so far not been implicated in
ISC nor SSPC function in general. While a role in ISC function
is not an absolute requirement for classiﬁer genes with higher
expression in ISCs, it is clearly intuitive. Therefore, we focused
on two such genes, Vgll4 and Lcp1, and examined the impact
of their shRNA-mediated gene suppression on intestinal orga-
noid growth. We used intestinal organoids from APCmin mouse
precancerous adenomas (Fig. 6A), since the upregulation of
the Wnt signaling pathway induces activation and expansion
of LGR51 ISCs and facilitates the analysis of stem cell pheno-
types [62, 63]. We expect that the results obtained from this
model can be extrapolated to wild-type ISCs as shown previ-
ously [63].
Figure 5. Somatic stem and progenitor cell (SSPC)-speciﬁc and discriminative genes include both known and novel players in SSPC biology.
(A): Correlation (Pearson’s r) (Cor) between the stemness probabilities (stemness p) assigned to intestinal organoid cells [9] and expression
of the stem cell markers Lgr5, Gnl3, and Cd44 as well as top (0.4) correlated TFs and metabolism-related genes. (B): All genes (sorted in
decreasing order of their logistic regression coefﬁcients) retained in the ﬁnal classiﬁer, and their overlap with population-derived ISC, NSC,
HSC, somatic stem cell (SC.Wong), and pluripotency (PluriNet) signatures, as well as their previous implication in proliferation/cell cycle [20].
Numbers correspond to the number of signature sets each gene is part of. (C): Overlap (–10*log_p) between the 23 genes retained in the
ﬁnal classiﬁer and population-derived stemness signatures, as visualized by StemChecker [20]. (D): t-SNE map of intestinal epithelial ex vivo
and organoid-derived LGR51 (classically considered as SCs) and LGR5- (assumed to be non-SCs) cells [9], depicting expression of the TFsMyc
and Etv6 (gray to orange gradient, orange highest expression). Abbreviations: HSC, hematopoietic stem cell; ISC, intestinal stem cell; NSC,
neural stem cell; TF, transcription factor.
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We ﬁrst demonstrated successful shRNA-mediated gene
suppression of the two genes in the murine CT26 colon carci-
noma cell line and intestinal organoids (Fig. S6A). While
shRNA-mediated gene suppression in CT26 cells did not affect
cell phenotype or proliferation per se (data not shown), we
observed a striking reduction in the number and size of intes-
tinal organoids in the gene suppression samples (Fig. 6B, 6C,
Supporting Information Fig. S6B–S6D). Strikingly, organoid
growth after Vgll4 gene suppression was completely impaired,
such that organoids could not be passaged and RNA could
not be collected for further experiments. For Lcp1, the gene
suppression effects were observed both at initial and subse-
quent passages (Fig. 6C, Supporting Information Fig. S6B–
S6D). Importantly, we also found that canonical stemness
marker genes such as Lgr5, Vdr, and the potential oncogene
Wwp1 [64], were signiﬁcantly downregulated at passage 0
when Lcp1 was suppressed, while Ki67, a proliferation marker,
showed no signiﬁcant difference (Fig. 6D, 6E). Further passag-
ing of these organoids (passage 3 and 4), showed that these
shRNA-mediated gene suppressions increased differentiation
markers such as Anpep (absorptive lineage) and Tff3 (secretory
lineage).
Together, these results demonstrate for the ﬁrst time the
requirement of two classiﬁer genes, Lcp1 and Vgll4, in APCmin
intestinal organoid growth and propagation. However, follow-up
studies will be required to consolidate the role of these genes in
stem cell function in general throughout many tissues.
DISCUSSION
Despite substantial progress in understanding SSPC function
and their essential role in maintaining and repairing
mammalian tissues, it is currently unknown how many kinds
of distinct SSPCs exist, which tissues harbor them and what
their molecular and functional similarities and differences are
[4, 5]. Recent technological developments in the ﬁeld of
scRNA-seq now facilitate analyses of unprecedented molecular
resolution, which enabled us to develop a universally applica-
ble method for the de novo identiﬁcation of self-renewing
and multipotent cells. The timeliness of our study is demon-
strated by the fact that numerous SSPC and non-SSPC scRNA-
seq datasets have only very recently become available,
enabling for the ﬁrst time cross-system analyses. Nevertheless,
we acknowledge that we were still constrained in the choice
of training and test sets, leading to overrepresentation of cer-
tain lineages (hematopoietic) and germ layers (mesoderm) in
our analyses as well as the lack of distinction between true
stem cells and multipotent progenitor cells. Ideally, all germ
layers and SSPC types (e.g., quiescent vs. active) should be
equally well represented in both training and test sets to
derive the best classiﬁer. Therefore, when more datasets will
become available, one can envisage updating and further scal-
ing up the binary classiﬁcation approach that we used here to
a multi-class system. The underlying aim would be to increase
the discriminative power of our approach by distinguishing
activated and quiescent somatic SCs, multipotent and unipo-
tent progenitors, for instance. This will in turn allow the
exploration of speciﬁc transcriptional properties for each of
the individual stages as well as detailed delineation of com-
monalities and differences between SSPCs.
A further limitation of our approach is the relative simplic-
ity of the used data normalization (quantiles), which dampens
the large dynamic expression range that is a powerful feature
of RNA-seq. We took this route given the large technical and
biological noise that is currently characterizing scRNA-seq
Figure 6. Effect of shRNA-mediated suppression of SSPC-discriminating genes in murine organoids. (A): Scheme of the isolation of intestinal
organoids from APCmin mice and the transduction with a lentiviral vector allowing shRNA-mediated gene suppression of Lcp1, Vgll4, or a con-
trol. (B, C): Organoid development is arrested upon Vgll4 and Lcp1 shRNA-mediated gene suppression at passage 0. Right (B), quantiﬁcation
of SC and RFP1 organoids expressing the shRNA-Vgll4. Images show representative organoids, both RFP1 (and thus expressing the shRNA)
and RFP- (which function as control) (bright ﬁeld, left and ﬂuorescence image, right). Scale bars: 200 mm. (C) Serial passaging (P0 to P4) of
intestinal organoids. Images show that the morphology of shRNA-Lcp1 expressing organoids was compromised compared to control organo-
ids in the third (P3) and fourth (P4) passage. Scale bar, 200 mm. Bottom left, quantiﬁcation of RFP1 organoids expressing the shRNA-Lcp1
over different passages. (D, E): Quantitative Reverse Transcription Polymerase Chain Reaction analyses of gene expression changes upon
shRNA-mediated gene suppression of Lcp1 in intestinal organoids showing downregulation of the stem cell markers Lgr5 and Vdr as well as
the potential tumour oncogene Wwp1 at passage 0 (D), and upregulation of the differentiation markers Tff3 and Anpep at passage 4. (E) The
proliferation marker Ki67 was not signiﬁcantly altered (D, E). Gapdh was used for normalization; *, p< .05. Abbreviation: SC, single cell.
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data, likely exacerbated by working across experimental and
data analysis protocols [65]. We anticipate that, with the
maturation of experimental and computational scRNA-seq
techniques, the actual distribution of expression estimates will
be taken into account, such that the full dynamic range of
this powerful method can be exploited.
Despite these limitations, we showed here that our SSPC
identiﬁcation method can be applied to previously completely
unseen scRNA-seq datasets, across different technologies
(e.g., CEL-seq and SMART-seq) [66, 67] and experimental sys-
tems, including highly proliferating (e.g., ISCs) and quiescent
(long-term HSCs) SSPCs. Consequently, we envision several
downstream applications for our classiﬁer. First, it may allow
the detection of stem-like cells in underexplored, heteroge-
neous tissues, with the aim of identifying speciﬁcally
expressed marker genes to enable downstream phenotypic
analyses, as shown here for the mouse epidermis and the
human pancreas. Indeed, while the markers that we propose
in these two systems will require further validation, we also
demonstrated the feasibility of marker detection given the de
novo identiﬁcation of the established markers LGR5 and GNL3
in intestinal epithelial organoids [62, 68]. Second, such a clas-
siﬁer may support estimating the fraction of stem-like cells in
a heterogeneous mix of cells. This may provide novel insights
into tissue organization, as we also illustrated here for the
epidermis and pancreas, or into a tissue’s or cell fraction’s
regenerative capacity, for example over the course of aging
[30], or to inform cell transplantation experiments [69]. A
third application is the detection of highly malignant cells in
tumors. That scRNA-seq data can be used in the context of
tumor heterogeneity to reveal stemness-exhibiting cells has in
fact recently been demonstrated in glioma samples [70].
While these latter applications go beyond the scope of the
current study, we envisage that they will constitute very fruit-
ful research areas in the future.
CONCLUSION
We developed a sc RNA-seq-based classiﬁer that accurately
detects SSPCs across tissues, aiding in the resolution of still
poorly characterized systems. In addition, we demonstrate
that this classiﬁer can provide a quantitative measure of a
cell’s progression along a differentiation path. The method’s
good cross-system performance supports the notion that
SSPCs can be recognized based on shared, but not necessarily
identical molecular properties. Speciﬁcally, genes with high
discriminative power have putative roles in SSPC biology, of
which many are known such as those of Myc and Ccnd2, but
others are novel such as Vgll4 and Lcp1’s function in the
intestinal system.
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